Biosynthetic alternatives to human donor corneal transplantation

人类供体角膜移植的生物合成替代品

• 批准号: 361222
• 负责人: Brunette Isabelle
• 金额: $ 23.43万
• 依托单位: Centre de recherche de l'Hôpital Maisonneuve-Rosemont (Montral)
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2016
• 资助国家: 加拿大
• 起止时间: 2016-10-01 至 2019-10-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=361222&lang=en
• 关键词: Bioengineering; Biosynthetic Corneal Substitute; Corneal Transplantation

The cornea is the outer window to the eye that transmits light to the retina for vision. Permanent transparency loss, due to disease or damage, can result in vision loss and blindness. Transplantation of human donor corneas is the only widely accepted tre

角膜是眼睛的外部窗口，将光线传输到视网膜以获得视觉。由于疾病或损伤造成的永久性透明度丧失可能导致视力丧失和失明。人类供体角膜移植是唯一被广泛接受的方法。